TECNOSALUD 2025: Peru’s Premier Healthcare Event—Your First Choice for Deepening Your Presence in the South American Market; Don’t Miss This Year’s Unmissable Showcase.

Exhibition Overview

Exhibition introduction

🔹Exhibition Scale: 10,017 square meters, up 12% from 2023;

🔹Exhibitor Composition: 348 companies Corporate exhibitors represent more than 20 countries, including China, India, Japan, and Germany, with Chinese companies accounting for 28% of the total.
🔹Audience Quality: Over ten thousand Professional visitors are in attendance, Among them, 60% are procurement decision-makers at healthcare institutions, covering end-users such as hospitals, laboratories, and clinics.

The Peruvian government has increased health spending to 5.5% of GDP and plans to promote pharmaceutical research and development through the National Health Innovation Plan. However, Domestic manufacturing capacity is limited, with import dependence exceeding 80% for medical equipment, particularly in areas such as imaging systems and surgical instruments where demand is robust. As Peru’s second-largest importer of medical products, China holds an 18.1% market share, and vaccines, artificial joints, and other products have entered the Peruvian market through trade fair platforms.

Peru has a population of 34.35 million, with an aging rate of 6.8%. The rise of the middle class is driving demand for high-end medical equipment and chronic disease management services. Peru’s pharmaceutical market is projected to reach several billion U.S. dollars by 2025, with an average annual growth rate of 8%. Consumers exhibit a strong preference for imported pharmaceutical products, and Chinese companies’ diabetes‑testing devices and blood‑pressure monitoring solutions have seen growing recognition in the Peruvian market.

Peru’s healthcare market is characterized by the coexistence of international giants and domestic players. International firms capture the high-end segment through technological partnerships, while local companies leverage their cost‑effectiveness to strengthen their foothold at the grassroots level. The challenge for Chinese companies lies in localizing their offerings, requiring them to leverage trade shows to gain insights into Peruvian consumers’ specific needs regarding product certification and after-sales service.

As a strategic gateway to the Latin American healthcare market, TECNOSALUD 2025 will offer exhibiting companies comprehensive opportunities for brand visibility, channel expansion, and policy insights. Booth reservations are now in the final sprint, with premium exhibition spaces in short supply. Companies looking to tap into the Peruvian and broader South American markets are encouraged to secure their spots early and reap the benefits of the global healthcare industry.

In addition, Our company offers a dedicated group‑exhibition service, with professional tour leaders providing全程陪同 and one‑stop exhibition support. We warmly invite those interested to join our group and exhibit. Enterprise , jointly exploring new opportunities in the South American healthcare market.